fda_list = [
    {
        "alert_date": "2025-11-01",
        "source": "DSC",
        "us_product": "Leqembi",
        "ingredient": "lecanemab",
        "form": "100 mg/mL 注射液",
        "risk_summary": "阿茲海默症 ARIA：APOE ε4 攜帶者風險增加",
        "action_summary": "建議基因檢測",
        "fda_excerpt": "FDA recommends MRI monitoring to reduce ARIA risk, especially in APOE ε4 carriers."
    },
    {
        "alert_date": "2025-10-15",
        "source": "DSC",
        "us_product": "Prolia",
        "ingredient": "denosumab",
        "form": "60 mg/1 mL 注射液",
        "risk_summary": "嚴重低血鈣：洗腎病人風險增加",
        "action_summary": "建議監測血鈣",
        "fda_excerpt": "Risk of severe hypocalcemia in dialysis patients receiving denosumab."
    },
    {
        "alert_date": "2025-09-30",
        "source": "DSC",
        "us_product": "Ocaliva",
        "ingredient": "obeticholic acid",
        "form": "5 mg 錠劑",
        "risk_summary": "原發性膽汁性肝硬化：晚期肝病病人風險增加",
        "action_summary": "建議調整劑量",
        "fda_excerpt": "Serious liver injury reported in non-cirrhotic PBC patients treated with obeticholic acid."
    }
]
